Rodrigo Moore‐Carrasco
- Biochemistry top 5%
- Phytochemicals and Antioxidant Activities 6
- Antioxidant Activity and Oxidative Stress 6
- Physiology top 5%
- Adipose Tissue and Metabolism 9
- Rehabilitation top 5%
-
- Diabetes, Cardiovascular Risks, and Lipoproteins 7
- Molecular Biology top 10%
- Peroxisome Proliferator-Activated Receptors 6
-
- Adipokines, Inflammation, and Metabolic Diseases 9
-
- Pharmacology and Obesity Treatment 6
-
- Antiplatelet Therapy and Cardiovascular Diseases 6
Rodrigo Moore‐Carrasco
56 papers receiving 1.7k citations
Peers
Comparison fields: 5 of 116
- Biochemistry 132
- Physiology 559
- Rehabilitation 83
- Endocrinology, Diabetes and Metabolism 193
- Molecular Biology 759
Countries citing papers authored by Rodrigo Moore‐Carrasco
This map shows the geographic impact of Rodrigo Moore‐Carrasco's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rodrigo Moore‐Carrasco with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rodrigo Moore‐Carrasco more than expected).
Fields of papers citing papers by Rodrigo Moore‐Carrasco
This network shows the impact of papers produced by Rodrigo Moore‐Carrasco. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rodrigo Moore‐Carrasco. The network helps show where Rodrigo Moore‐Carrasco may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Rodrigo Moore‐Carrasco, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 2 | |
| 3 | 2023 | 4 | |
| 4 | 2017 | 14 | |
| 5 | 2015 | 1 | |
| 6 | 2013 | 19 | |
| 7 | 2011 | 50 | |
| 8 | 2011 | 45 | |
| 9 | 2010 | 37 | |
| 10 | Both AP-1 and NF-kappaB seem to be involved in tumour growth in an experimental rat hepatoma. | 2009 | 10 |
| 11 | Antiagregantes plaquetarios: mecanismos de acción y riesgos asociados al uso | 2009 | 2 |
| 12 | 2009 | 6 | |
| 13 | Fisiopatología del estado protrombótico en el síndrome metabólico | 2009 | 1 |
| 14 | 2007 | 55 | |
| 15 | 2005 | 48 | |
| 16 | 2005 | 66 | |
| 17 | 2005 | 29 | |
| 18 | 2004 | 26 | |
| 19 | 2003 | 92 | |
| 20 | 2003 | 35 |
About Rodrigo Moore‐Carrasco
Rodrigo Moore‐Carrasco is a scholar working on Biochemistry, Endocrinology, Diabetes and Metabolism and Physiology, having authored 57 papers that have together received 1.7k indexed citations. Recurring topics across this work include Adipokines, Inflammation, and Metabolic Diseases (9 papers), Adipose Tissue and Metabolism (9 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (7 papers), Pharmacology and Obesity Treatment (6 papers), Phytochemicals and Antioxidant Activities (6 papers), Peroxisome Proliferator-Activated Receptors (6 papers), Antiplatelet Therapy and Cardiovascular Diseases (6 papers) and Antioxidant Activity and Oxidative Stress (6 papers). The work is most often cited by research in Biochemistry (132 citations), Physiology (559 citations) and Rehabilitation (83 citations). Rodrigo Moore‐Carrasco has collaborated with scholars based in Chile, Spain and Brazil. Frequent co-authors include Josep M. Argilés, Sı́lvia Busquets, Iván Palomo, Francisco J. López‐Soriano, Francisco Monsalve, Radha D. Pyarasani, Fernando Delgado‐López, Eduardo Fuentes, Marcelo Alarcón and Gemma Fuster. Their work appears in journals such as The Journal of Physiology, Cancer Research and FEBS Letters.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.